Charles River Newsroom

Wall Street Roars Back From April Tariff Sell-Off: Which Sectors Are Still Underwater?

BenzingaMay 2 15:28 ET

Earnings Preview: CRL to Report Financial Results Pre-market on May 07

Moomoo NewsMay 1 21:00 ET

Charles River Associates Backs FY25 Revenue View $715M-$735M, Consensus $718.35M

TipRanksMay 1 09:30 ET

Press Release: Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.49 Per Common Share

Dow JonesMay 1 08:14 ET

Press Release: Charles River Associates (CRA) Reports Financial Results for the First Quarter of 2025

Dow JonesMay 1 08:13 ET

Earnings Flash (CRAI) CHARLES RIVER ASSOCIATES Reports Q1 Adjusted EPS $2.22, Vs. FactSet Est of $1.95

MT NewswiresMay 1 08:05 ET

Express News | Charles River Associates (CRA) Reports Financial Results for the First Quarter of 2025

ReutersMay 1 08:05 ET

Charles River Associates Declares Dividend of 49c >CRAI

Dow JonesMay 1 08:02 ET

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

Yahoo FinanceApr 29 08:00 ET

Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.

Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.

Zhitong FinanceApr 28 05:09 ET

Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus

Seeking AlphaApr 27 14:10 ET

The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.

A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.

Zhitong FinanceApr 25 23:38 ET

Vanda Claims FDA 'Unlawfully' Delays Hearing Request on Tradipitant Decision

Seeking AlphaApr 23 16:58 ET

9 Health Care Stocks With Whale Alerts In Today's Session

BenzingaApr 22 13:35 ET

Humanized Mouse and Rat Model Market Worth US$409.8 Million in 2030 With 8.2% CAGR | MarketsandMarkets

PR NewswireApr 22 10:30 ET

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break

Yahoo FinanceApr 22 10:01 ET

Charles River Associates (CRA) Strengthens Its Risk, Investigations & Analytics Practice

Yahoo FinanceApr 22 08:30 ET

Research Alert: CFRA Keeps Hold View On Shares Of Charles River Laboratories International Inc.

MT NewswiresApr 21 17:40 ET

Express News | Charles River Laboratories International Inc : Jefferies Cuts Target Price to $100 From $169

ReutersApr 21 00:59 ET

Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus

Seeking AlphaApr 20 09:05 ET